Piramal Pharma informs about updates

10 Jul 2025 Evaluate
Piramal Pharma has informed that as per the information received by the Company on July 08, 2025, NSE Sustainability Ratings and Analytics (‘NSE Sustainability’), has assigned an Environment, Social, and Governance (‘ESG’) Rating of ‘61’ for the Company for the FY 2023-24 based on data made available by the Company in public domain for that year. The link for the rating as published is also available on the website of NSE Sustainability - NSE Sustainability Ratings & Analytics. Please note that the Company has not engaged NSE Sustainability for ESG Rating. NSE Sustainability has voluntarily prepared the report considering the ESG factors reported by the Company.

The above information is a part of company’s filings submitted to BSE.

Piramal Pharma Share Price

179.95 -0.60 (-0.33%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×